v3.22.4
BUSINESS COMBINATIONS - Pega Medical and MD Orthopaedics (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Jul. 01, 2022
Apr. 01, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Business Acquisition          
Cash paid to acquire     $ 8,360 $ 0 $ 0
Common stock, par value (in dollars per share)     $ 0.00025 $ 0.00025  
Pega Medical          
Business Acquisition          
Total consideration transferred $ 32,045        
Cash paid to acquire 32,042        
Amount of Stock as consideration (in shares) $ 3        
Business acquisition share price trading period 3 years        
Contingent Consideration $ 1,052        
Contingent consideration liability term 18 months        
Contingent repurchase price, per share (in dollars per share) $ 0.1        
Acquisition related costs $ 382        
Pega Medical | Restricted Stock Units          
Business Acquisition          
Issuance of common stock $ 499        
Vesting period (in years) 3 years        
Pega Medical | Common Stock          
Business Acquisition          
Consideration for acquisition (in shares) 34,899,000        
Common stock, par value (in dollars per share) $ 0.00025        
Issuance of common stock $ 1,497        
Common stock (in dollars per share) $ 42.9        
MD Orthopaedics          
Business Acquisition          
Total consideration transferred   $ 18,487      
Cash paid to acquire   $ 8,781      
Consideration for acquisition (in shares)   173,241      
Common stock, par value (in dollars per share)   $ 0.00025      
Issuance of common stock   $ 9,707      
Common stock (in dollars per share)   $ 56.03      
Acquisition related costs   $ 381